Journal article

The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient- and treatment-related factors

Nicole Kiss, Elisabeth Isenring, Karla Gough, Meinir Krishnasamy

Clinical Nutrition | CHURCHILL LIVINGSTONE | Published : 2014

Abstract

BACKGROUND & AIMS: Thoracic radiotherapy is associated with toxicities that can adversely impact nutritional intake. This study aimed to investigate the prevalence and predictors of ≥5% weight loss and commencement of enteral nutrition in lung cancer patients receiving radiotherapy. METHODS: A retrospective study of 96 patients treated with high dose palliative or radical radiotherapy for a primary diagnosis of small cell or non-small cell lung cancer. Weight loss was calculated between the start and up to 90 days from radiotherapy commencement. Associations between ≥5% weight loss and enteral feeding, and demographic and clinical factors (age, gender, nutritional status, total dose of radio..

View full abstract

Grants

Funding Acknowledgements

The study was supported by a PhD scholarship from the Victorian Cancer Agency, Melbourne, Australia. The sponsors had no involvement in the study.